Whittier Trust CO Novartis Ag Transaction History

Whittier Trust CO

  • $7.47 Billion
  • Q4 2024

A detailed history of Whittier Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Whittier Trust CO holds 52,678 shares of NVS stock, worth $5.76 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
52,678
Previous 47,605 10.66%
Holding current value
$5.76 Million
Previous $5.48 Million 6.37%
% of portfolio
0.07%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$96.78 - $117.18 $490,964 - $594,454
5,073 Added 10.66%
52,678 $5.13 Million
Q3 2024

Oct 21, 2024
BUY
$106.13 - $120.89 $70,364 - $80,150
663 Added 1.41%
47,605 $5.48 Million
Q2 2024

Jul 26, 2024
SELL
$92.57 - $107.37 $81,739 - $94,807
-883 Reduced 1.85%
46,942 $5 Million
Q1 2024

May 02, 2024
BUY
$95.27 - $108.47 $15,529 - $17,680
163 Added 0.34%
47,825 $4.63 Million
Q4 2023

Jan 11, 2024
SELL
$92.27 - $101.54 $24,728 - $27,212
-268 Reduced 0.56%
47,662 $4.81 Million
Q3 2023

Oct 27, 2023
BUY
$94.73 - $105.13 $36,092 - $40,054
381 Added 0.8%
47,930 $4.88 Million
Q2 2023

Jul 24, 2023
SELL
$92.52 - $104.91 $72,720 - $82,459
-786 Reduced 1.63%
47,549 $4.8 Million
Q1 2023

Apr 21, 2023
SELL
$80.03 - $92.81 $38,814 - $45,012
-485 Reduced 0.99%
48,335 $4.45 Million
Q4 2022

Jan 25, 2023
SELL
$75.55 - $92.52 $182,151 - $223,065
-2,411 Reduced 4.71%
48,820 $0
Q3 2022

Oct 21, 2022
BUY
$74.61 - $87.26 $214,802 - $251,221
2,879 Added 5.95%
51,231 $3.89 Million
Q2 2022

Jul 28, 2022
BUY
$80.52 - $93.75 $37,441 - $43,593
465 Added 0.97%
48,352 $4.09 Million
Q1 2022

Apr 29, 2022
SELL
$80.11 - $90.62 $99,736 - $112,821
-1,245 Reduced 2.53%
47,887 $4.2 Million
Q4 2021

Jan 19, 2022
SELL
$79.7 - $88.13 $224,674 - $248,438
-2,819 Reduced 5.43%
49,132 $4.3 Million
Q3 2021

Nov 01, 2021
SELL
$81.78 - $95.14 $8,096 - $9,418
-99 Reduced 0.19%
51,951 $4.25 Million
Q2 2021

Jul 29, 2021
SELL
$85.24 - $94.15 $207,559 - $229,255
-2,435 Reduced 4.47%
52,050 $4.75 Million
Q1 2021

Apr 26, 2021
SELL
$83.5 - $98.47 $139,946 - $165,035
-1,676 Reduced 2.98%
54,485 $4.66 Million
Q4 2020

Jan 29, 2021
SELL
$78.07 - $94.43 $106,799 - $129,180
-1,368 Reduced 2.38%
56,161 $5.3 Million
Q3 2020

Oct 30, 2020
SELL
$82.14 - $91.0 $121,156 - $134,225
-1,475 Reduced 2.5%
57,529 $5 Million
Q2 2020

Jul 10, 2020
SELL
$80.93 - $91.1 $636,109 - $716,046
-7,860 Reduced 11.76%
59,004 $5.15 Million
Q1 2020

Apr 27, 2020
SELL
$70.67 - $99.01 $190,243 - $266,534
-2,692 Reduced 3.87%
66,864 $5.51 Million
Q4 2019

Jan 31, 2020
SELL
$84.35 - $95.37 $20,665 - $23,365
-245 Reduced 0.35%
69,556 $6.59 Million
Q3 2019

Oct 18, 2019
BUY
$85.54 - $94.26 $703,480 - $775,194
8,224 Added 13.36%
69,801 $6.07 Million
Q2 2019

Jul 23, 2019
BUY
$75.4 - $92.8 $132,553 - $163,142
1,758 Added 2.94%
61,577 $5.62 Million
Q1 2019

Apr 29, 2019
SELL
$75.32 - $86.15 $161,260 - $184,447
-2,141 Reduced 3.46%
59,819 $5.75 Million
Q4 2018

Feb 07, 2019
SELL
$73.66 - $82.02 $134,945 - $150,260
-1,832 Reduced 2.87%
61,960 $5.32 Million
Q3 2018

Oct 23, 2018
SELL
$66.94 - $77.43 $306,852 - $354,939
-4,584 Reduced 6.7%
63,792 $5.5 Million
Q2 2018

Jul 27, 2018
SELL
$64.91 - $73.36 $1.74 Million - $1.97 Million
-26,787 Reduced 28.15%
68,376 $5.17 Million
Q2 2018

Jul 20, 2018
BUY
$64.91 - $73.36 $1.65 Million - $1.87 Million
25,463 Added 36.53%
95,163 $8.62 Million
Q1 2018

May 01, 2018
BUY
$70.39 - $84.15 $117,269 - $140,193
1,666 Added 2.45%
69,700 $5.64 Million
Q4 2017

Feb 07, 2018
SELL
$72.33 - $77.64 $731,545 - $785,250
-10,114 Reduced 12.94%
68,034 $5.71 Million
Q3 2017

Oct 23, 2017
BUY
$74.14 - $77.27 $5.79 Million - $6.04 Million
78,148
78,148 $6.71 Million

Others Institutions Holding NVS

# of Institutions
1,473
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email